The Brazil therapeutic respiratory devices market size is expected to reach USD 502.71 million in 2030 and is expected to grow at a CAGR of 6.5% from 2025 to 2030. Growing geriatric population, and increasing prevalence of respiratory diseases are the key factors that are driving the growth. Moreover, the market is expected to grow owing to rapid technological advancements in the healthcare sector. Furthermore, respiratory monitoring devices use software applications for the collection and analysis of data from ventilators equipped with the health system.
The availability of ventilators during the COVID-19 pandemic has significantly improved operational capabilities. Organizations like the American Association for Respiratory Care collaborated to train respiratory therapists in ventilator operation, thereby boosting market players to increase production capacity. For example, Royal Philips aimed to double hospital ventilator production by May 2020 and achieve a four-fold growth by Q3 2020.
The growing prevalence of respiratory diseases is a major growth driver for this market. According to the World Health Organization (WHO), COPD caused 3.23 million deaths in 2019, making it the third leading cause of death globally. Additionally, WHO projects that by 2030, lung cancer, tuberculosis, COPD, and pneumonia will account for approximately one in five deaths worldwide, up from one-sixth of all deaths in 2008.
The market is expected to witness intense competition due to the influx of numerous startups seeking opportunities in this sector. For instance, Magnamed, a startup based in São Paulo, announced in April 2020 that it would collaborate with leading Brazilian and multinational corporations to produce 6,500 ventilators by August 2020. This initiative, supported by FAPESP, addresses the urgent need for respiratory devices in treating COVID-19 patients. The growing support for such startup initiatives is anticipated to foster competition within the market, driving innovation and advancements in respiratory care.
This product will be delivered within 1-3 business days.
The availability of ventilators during the COVID-19 pandemic has significantly improved operational capabilities. Organizations like the American Association for Respiratory Care collaborated to train respiratory therapists in ventilator operation, thereby boosting market players to increase production capacity. For example, Royal Philips aimed to double hospital ventilator production by May 2020 and achieve a four-fold growth by Q3 2020.
The growing prevalence of respiratory diseases is a major growth driver for this market. According to the World Health Organization (WHO), COPD caused 3.23 million deaths in 2019, making it the third leading cause of death globally. Additionally, WHO projects that by 2030, lung cancer, tuberculosis, COPD, and pneumonia will account for approximately one in five deaths worldwide, up from one-sixth of all deaths in 2008.
The market is expected to witness intense competition due to the influx of numerous startups seeking opportunities in this sector. For instance, Magnamed, a startup based in São Paulo, announced in April 2020 that it would collaborate with leading Brazilian and multinational corporations to produce 6,500 ventilators by August 2020. This initiative, supported by FAPESP, addresses the urgent need for respiratory devices in treating COVID-19 patients. The growing support for such startup initiatives is anticipated to foster competition within the market, driving innovation and advancements in respiratory care.
Brazil Therapeutic Respiratory Devices Market Report Highlights
- The degree of innovation in Brazil is high, with advancements focused on improving device portability, efficiency, and patient comfort. Companies are integrating smart technologies into respiratory devices, such as remote monitoring and AI-based diagnostics
- The nebulizers segment held the largest revenue share of 24.79% in 2024 due to their effectiveness in delivering medication directly to the lungs for treating respiratory conditions like asthma and COPD.
- The electrostatic filtration segment dominated the market due to its efficiency in trapping airborne particles and pathogens
- The ventilator filter segment held the largest revenue market share due to the critical role these filters play in ensuring the safety and efficacy of mechanical ventilation
- This report forecasts volume & revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030.
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This Report Addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Market Variables, Trends, & Scope
Chapter 4. Brazil Therapeutic Respiratory Devices Market: Product Estimates & Trend Analysis
Chapter 5. Brazil Therapeutic Respiratory Devices Market: Technology Estimates & Trend Analysis
Chapter 6. Brazil Therapeutic Respiratory Devices Market: Filter Estimates & Trend Analysis
Chapter 7. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- Koninklijke Philips NV
- Medtronic
- Masimo
- Chart Industries
- Hamilton Medical
- BD (Becton, Dickinson and Company)
- ResMed Inc.
- General Electric Company (GE HealthCare)
- Drägerwerk AG & Co. KGaA
- Fisher & Paykel Healthcare Limited
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 110 |
Published | March 2025 |
Forecast Period | 2024 - 2030 |
Estimated Market Value ( USD | $ 343.74 Million |
Forecasted Market Value ( USD | $ 502.71 Million |
Compound Annual Growth Rate | 6.5% |
Regions Covered | Brazil |
No. of Companies Mentioned | 10 |